Respiratory syncytial virus (RSV) is increasingly recognized as a significant cause of adult respiratory illness. We evaluated routine viral testing and discharge diagnoses for identifying RSV and influenza burden. Polymerase chain reaction results performed in adults during emergency room visits or hospitalizations were reviewed. Peak RSV activity preceded influenza activity by 8 weeks. The ratio of total number of viral tests performed divided by total number of respiratory visits was higher during influenza than RSV peaks (1.31 vs 0.72; P = .0001). Influenza and RSV were listed primary diagnoses in 56 (30%) vs 7 (6%), respectively (P < .0001). Routine viral testing to estimate adult RSV disease burden has limitations.
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Respiratory syncytial virus (RSV) is widely recognized as the most common cause of bronchiolitis and pneumonia in young children [1, 2] . Immunity to RSV is incomplete and reinfection occurs throughout life [3] . In healthy adults, RSV illness is generally mild [4] . However, elderly persons and those with chronic cardiopulmonary illnesses or immunosuppressive conditions may have severe disease [5, 6] . Recent surveillance and mathematical modeling studies suggest that RSV is second only to influenza as an important viral pathogen in older adults, leading to significant morbidity and mortality [5, [7] [8] [9] . Efforts to develop RSV vaccines and therapeutics for use in adults are under way, but experts agree that additional epidemiologic data in these populations would be beneficial for study design and implementation strategies [10] . One effect of the 2009 influenza pandemic has been that many clinical laboratories perform influenza testing with sensitive polymerase chain reaction (PCR) assays. As most commercial PCR assays are duplexed with RSV or multiplexed for the detection of multiple viral pathogens, adult RSV infections are now being identified more frequently as part of routine medical care. Thus, these viral databases, especially coupled with clinical data available in electronic medical records (EMRs), could provide readily accessible information to assess the burden of adult RSV disease. Although influenza and RSV circulate during the winter in temperate climates, peaks of RSV and influenza activity may not always coincide. Because viral diagnostic assays may be performed in adults primarily to identify influenza, their use may be underutilized when RSV activity is temporally distinct from influenza activity. If so, testing bias may affect the accuracy of laboratory and EMR data for assessing RSV disease burden in adults.
Therefore, we evaluated viral testing performed as part of routine care for evidence of testing bias during one winter viral respiratory season. In addition, we collated primary and secondary discharge diagnoses from the EMR for patients with positive influenza or RSV tests during the same period to assess the accuracy of discharge diagnoses for RSV illness.
METHODS

Study Design
The study was a retrospective medical record and laboratory review performed at Rochester Regional Health in Rochester, New York, from 15 October 2015 to 15 May 2016. The clinical microbiology laboratory provides services for 2 hospitals, adult and pediatric outpatient practices, and facilities for elderly adults. The majority of inpatient and emergency services are provided at Rochester General Hospital (RGH), a 528-bed acute-care community teaching hospital. Inpatient services are primarily for adults with only a small inpatient pediatric ward. The study was approved by the Rochester Regional Health and the University of Rochester institutional review boards.
Laboratory Methods
The microbiology laboratory utilizes 3 methods for viral detection: 2 PCR-based assays and tissue culture. The majority of samples for influenza or respiratory viral testing were processed with the Simplexa Influenza/RSV PCR assay (Focus Diagnostics, Cypress, California). If requested, real-time multiplex PCR using the FilmArray Respiratory Panel (Idaho Technologies, Salt Lake City, Utah) was performed. Total respiratory PCR tests requested and positive influenza and RSV results per week during the study period were tabulated.
Clinical Data Collection
RGH utilizes the Epic Hyperspace Epic 2015 electronic medical record. We collected the number of emergency department (ED) visits and hospital admissions for adults and children to RGH consistent with an acute respiratory illness (ARI) based on International Classification of Diseases, Tenth Revision (ICD-10) discharge diagnosis codes: pneumonia and influenza (J09-J18), viral illness (B34), URI (J00-J06), bronchitis and bronchiolitis (J20-22), chronic obstructive pulmonary disease (COPD) with infection (J44.0) or acute exacerbation (44.1), asthma with acute exacerbation (J45.4, J45.5, J45.9), and acute respiratory failure (J96.00-J96.22, J96.91-92). In addition, the EMR of all subjects admitted to RGH during the study period who were positive for influenza or RSV were reviewed for primary and secondary discharge diagnoses.
Statistical Analysis
Peak RSV and influenza periods were defined as the 5 weeks during which the percentage positive rate of samples tested was ≥20%. To test the equivalence of viral testing rates during periods of peak RSV and influenza activity, and to construct 95% confidence intervals (CIs) for rates and differences thereof, a large sample Z-test based on Poisson distributional assumptions was used to compare the rates of tests performed per ED and hospital admission for respiratory related illness. For patients with positive RSV or influenza tests, the percentages of subjects with a primary or any discharge diagnosis noting the specific viral infection in the EMR were compared by Fisher exact test.
RESULTS
From 15 October 2015 to 15 May 2016, a total of 7827 viral respiratory PCR assays were performed in the clinical laboratory at RGH (Figure 1 ). This testing represented inpatient and outpatient samples obtained from children and adults and >95% were performed using the duplex Simplexa assay. Of these, 3995 (51%) tests were performed on samples from patients in ED or from inpatients, and 3792 (95%) were from adults and 203 (5%) were from children. Of the adult ED and inpatient tests performed, 136 were positive for RSV and 417 for influenza. Eleven nosocomial influenza cases were excluded from analysis. Most of the adult RSV detections were in hospitalized patients (110 admissions vs 26 seen in ED and discharged), whereas influenza cases were more evenly split (188 admissions vs 218 seen in ED and discharged).
The peak RSV and influenza activity as judged by all positive test results, including outpatients and children, indicated that RSV peaked during weeks 2-6 (9 January to 6 February 2016) and influenza was most active during weeks 10-14 (5 March to 2 April 2016). The RSV peak was lower but more sustained compared to the sharp rise and decline of influenza ( Figure 2A ). The number of tests conducted in adults seen in ED and hospitalized during RSV peak weeks was 537 compared to 1260 tests during influenza peak weeks ( Figure 2B) . Notably, the number of respiratory illnesses as determined by ICD-10 coding only increased from 739 to 958 during the same 2 periods. Thus, for adult patients seen in ED or hospital, the number of overall viral tests conducted divided by the number of respiratory illnesses was 0.73 (95% confidence interval [CI], .67-.79) during RSV peak and 1.32 (95% CI, 1.24-1.39), during the influenza peak (P < .0001). Viral testing was performed for a variety of conditions not typically considered "respiratory illness" including alcohol withdrawal, pulmonary embolism, falls, gastroenteritis, and pulmonary edema.
Review of the EMR indicated significant differences in coding practices for 110 RSV-and 188 influenza-related adult admissions. Only 7 (6%) medical records of hospitalized RSV cases listed RSV as the primary discharge diagnosis, whereas 56 (51%) included RSV in any ICD-10 discharge diagnosis. Most commonly, underlying conditions (COPD, asthma, congestive heart failure) or complications (respiratory failure, dehydration, falls, arrhythmia) were noted as the primary discharge diagnosis of RSV patients. Notation of influenza in adult discharge diagnoses was significantly more common, with 56 (30%) listing influenza as the primary diagnosis and 149 (79%) noting influenza in any discharge diagnosis (P = .0001 for all comparisons).
During the same time period, 42 children tested positive for RSV (25 admissions and 17 ED) and 40 were positive for influenza (13 admissions and 27 ED). A similar pattern of more frequent viral testing during periods of influenza was also observed in children. divided by number of respiratory visits to ED or admissions was 0.16 (95% CI, .16-.17) during the RSV peak and 0.44 (95% CI, .43-.44) during the influenza 5-week peak period (P < .0001). Pediatric coding practices were significantly different than what was observed in adults. Sixty percent of RSV admissions listed RSV as the primary discharge diagnosis and 68% included RSV in any secondary diagnosis. Influenza was listed as the primary discharge diagnosis in 77% and in secondary diagnoses in 90% of hospitalized children with positive influenza tests.
DISCUSSION
Thus far, estimates of RSV disease burden in adults have been limited to relatively expensive active surveillance studies or mathematical modeling of large, publicly available data sets [5, 7-9, 11, 12] . Our study represents the first assessment of the utility of routine diagnostic viral PCR testing as an estimate of adult RSV disease burden. Influenza and RSV circulate predominately in winter, but periods of peak activity may vary. Thus, impact of testing bias may vary from year to year depending upon the degree of overlap of viral circulation. In our study, the peaks of viral activity were temporally separated by 8 weeks, permitting assessment of potential testing bias. Our data clearly indicate that increased viral testing occurred for both children and adults when influenza was prevalent in the community. Influenza epidemics frequently result in media coverage and campaigns from infection prevention programs to increase awareness of viral circulation. In addition, fever is more common with influenza and may prompt clinicians to consider viral testing [13] . Interestingly, during periods of influenza activity, the number of viral tests done exceeded the number of adult patients in ED or admitted with ICD-10 codes consistent with acute respiratory diagnoses. We found that clinicians were testing for influenza in patients with a variety of conditions, including confusion, undifferentiated fever, dehydration, and exacerbations of chronic diseases, that were not captured in our review of respiratory diagnoses. Compared to RSV, influenza was detected twice as frequently in hospitalized patients and 10 times more often in patients treated and released from the ED based on routine testing data. However, if testing was applied in a standardized fashion, these differences may have been less dramatic. Although the number of children in our study was small and RSV is a well-recognized pediatric pathogen, the same testing pattern was observed. This may reflect in part the de-emphasis on routine RSV testing by recent pediatric guidelines [14] .
It is not surprising to find that diagnostic tests that include influenza and RSV would be ordered more often during periods of high influenza activity as influenza diagnosis has practical implications for clinicians. In contrast, specific antiviral agents are not currently available for RSV and thus testing is less urgent. One might postulate that a viral diagnosis of any kind could be beneficial and lead to less additional diagnostic testing and potentially reduce antibiotic use, but presently the value of expensive multiplex viral testing on a routine basis can be debated [15] .
Additionally, we found that ICD-10 discharge diagnoses in adults do not fully capture the impact of both viruses, especially RSV. RSV is not widely appreciated as an adult pathogen by many internists. Even when RSV is identified, its role as the initial trigger for exacerbations of chronic medical conditions is often overlooked. It may be thought that the virus is irrelevant, and until there are effective methods of prevention and treatment, this attitude may be difficult to dispel. Our data indicate that studies utilizing ICD-10 discharge diagnoses to identify cases of adult RSV infection will substantially underestimate the problem as RSV infection was documented in discharge coding in only 51% of cases. Notably, pediatricians were more likely to ascribe a serious respiratory illness requiring a hospitalization, as reflected in ICD-10 coding, and therefore these types of databases may be more useful for pediatric research.
The primary limitation of this study is that our analysis reflects 1 year of study at a single community healthcare system. Testing practices may differ at other types of institutions and in other geographic locations and therefore conclusions cannot be generalized. It is also likely the coding practices may vary by locations and for different EMR systems. Multiple-year studies during which the timing of the influenza and RSV epidemic varies would also provide a better understanding of the overall effect of testing bias. Concurrent prospective studies with standardized testing criteria would be useful to judge the extent of testing bias.
The availability of RSV testing on a routine basis has multiple potential benefits. It will likely increase awareness of RSV as an adult pathogen, infected patients could be enrolled in clinical trials of new therapeutic agents, and unnecessary antibiotic use might be curtailed. However, the use of routine testing data to assess adult disease burden should be made with caution and with an understanding of the limitations of these data.
Notes
